Literature DB >> 225063

Enzymes of collagen biosynthesis in skin and serum and dermatological diseases. II. Serum enzymes.

E R Kuutti-Savolainen.   

Abstract

Serum immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity were measured in 54 patients wtih various dermatological diseases and compared with corresponding values in 32 control subjects. These serum enzymes were at the control level in the great majority of the patients, and no correlation was found between serum and skin enzymes, except for one weak correlation in lichen ruber planus. Some patients with psoriasis, lichen ruber planus, keloids, erythema nodosum or chronic discoid lupus erythematosus, however, did have at least one of these enzymes elevated in the serum, and a significant correlation (P less than 0.01) between the two enzymes was found in the total disease material. Thus it does seem that diseases limited only to the skin can sometimes raise these serum enzyme levels. The mean levels of serum immunoreactive prolyl hydroxylase and galactosylhydroxylysyl glucosyltransferase activity were significantly elevated (P less than 0.001) in active systemic connective tissue diseases such as systemic lupus erythematosus, scleroderma or dermatomyositis compared with the controls, and 4 out of 7 values for immunoreactive prolyl hydroxylase and 3 out of 7 for galactosylhydroxylysyl glucosyltransferase activity were above the 95% confidence limit of the controls. Since the levels of the skin enzymes were not elevated in most of these patients, however, the main sources for the elevated serum enzymes were probably tissues other than the skin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225063     DOI: 10.1016/0009-8981(79)90051-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum.

Authors:  T E Takala; J Vuori; H Anttinen; K Väänänen; R Myllylä
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

2.  Serum immunoreactive prolyl hydroxylase in inflammatory rheumatic diseases.

Authors:  E R Kuutti-Savolainen; K I Kivirikko; O Laitinen
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

3.  Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis.

Authors:  E R Savolainen; T A Miettinen; P Pikkarainen; M P Salaspuro; K I Kivirikko
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

4.  Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment.

Authors:  P Autio; J Risteli; U Kiistala; L Risteli; J Karvonen; A Oikarinen
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

5.  Human prolyl hydroxylase. Purification, radioimmunoassay and clinical studies in liver diseases.

Authors:  Y Nagai; H Oka
Journal:  Gastroenterol Jpn       Date:  1985-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.